Dr Jennifer Boer is the Theme Leader for Immunity and Metabolism within the Accelerator for Translational Research and Clinical Trials (ATRACT) centre and a research fellow in the Cancer Aging and Vaccines Laboratory (CAVA).
Jennifer’s translational research centres on leveraging high-dimensional transcriptomics and big data methodologies to elucidate the complex immunomodulatory effects of both conventional and nanoparticle-based vaccines across the critical domains of infectious diseases and oncology, with particular focus on age and sex differences. Her profound cross-disciplinary expertise spans biotechnology, immunology/vaccinology and advanced bioinformatics. She has been recognised with competitive research accolades, including a 10X Genomics single-cell RNA sequencing (scRNAseq) fellowship and several major supercomputer merit allocations, such as 2 consecutive awards of the RACE Merit Allocation Scheme and the NCI Adaptor Grant (with over ~250kSUs).
Jennifer is the co-founder and co-leader of the RMIT Bioinformatics Platform and the founder and leader of the graduate course, Bioinformatics and Multi-omics Analysis. She serves as a Board Member on the RMIT Research Compute Governance (RCG) Committee, the Australian Society of Immunology (ASI) Systems Immunology Victorian/Tasmanian State Representative, and provides expert bioinformatics/biostatistics input to clinical, biotechnology, and platform infrastructure organizations
Immunology, Clinical Sciences, Oncology and Carcinogenesis, Nanotechnology, Other Medical and Health Sciences

RMIT University acknowledges the people of the Woi wurrung and Boon wurrung language groups of the eastern Kulin Nation on whose unceded lands we conduct the business of the University. RMIT University respectfully acknowledges their Ancestors and Elders, past and present. RMIT also acknowledges the Traditional Custodians and their Ancestors of the lands and waters across Australia where we conduct our business - Artwork 'Sentient' by Hollie Johnson, Gunaikurnai and Monero Ngarigo.
Learn more about our commitment to Aboriginal and Torres Strait Islander peoples